Winning the Russian Pharma Awards® means recognition by most demanding audience, which are doctors. About 430,000 doctors united by the Doctor at Work communication platform took part in the voting.
The award ceremony took place on November 24th in Soho Rooms, Moscow.
Nomides® is indicated to treat influenza in adults and children over the age of 1 year. Nomides® (INN Oseltamivir) significantly shortens the period of clinical manifestations of influenza infection, reduces their severity and the frequency of influenza complications, shortens the time of viral shedding. The drug should be used no later than 40 hours since symptoms onset.
Currently, Nomides® is the only Oseltamavir on the Russian market produced in two forms, as 10 g, 15 g and 30 g powder for suspension and 30, 45, 75 mg capsules.
The 4th place winner in the category “Therapy of severe pain syndrome in osteoarthritis” of this popular award in the field of pharmacy and medicine was Etorelex (INN Etoricoxib), another drug produced by Pharmasyntez, which belongs to the group of non-steroidal anti-inflammatory drugs.
More information about these drug products can be found on the following websites: